Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04929678 · ClinicalTrials.gov registry record · NA
Study of the Braive Growth Modulation System for Progressive Pediatric Scoliosis
A NA study, sponsored by Medtronic Spinal and Biologics.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT04929678: Clinical Trial NA study, sponsored by Medtronic Spinal and Biologics.
NCT04929678 is a NA study that was terminated before completion, run by Medtronic Spinal and Biologics. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04929678, a NA study, was terminated before completion, sponsored by Medtronic Spinal and Biologics.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study was to establish probable benefits and evaluate the safety and preliminary effectiveness of the Braive™ GMS when used in the treatment of pediatric progressive scoliosis.
Primary Outcome
Device related adverse events are any untoward medical occurrence, unintended disease or injury, or untoward clinical signs (including abnormal laboratory findings) in subjects, users or other persons, related to the investigational medical device whether anticipated or unanticipated. Summary will be based on both Investigators and Medtronic relatedness assessment.
Interventions
- DEVICE Braive™ Growth Modulation System (Braive™ GMS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-08-12 |
| Est. Completion | 2026-01-14 |
| Phase | NA |
Why NCT04929678 stopped before completion
NCT04929678 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Braive™ Growth Modulation System (Braive™ GMS) is the first listed.
NCT04929678 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04929678 about?
NCT04929678 is a clinical study titled "Study of the Braive Growth Modulation System for Progressive Pediatric Scoliosis". The purpose of this study was to establish probable benefits and evaluate the safety and preliminary effectiveness of the Braive™ GMS when used in the treatment of pediatric progressive scoliosis.
What is the current status of trial NCT04929678?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2021-08-12. Estimated completion is 2026-01-14.
What interventions are being tested in trial NCT04929678?
The interventions under investigation include: Braive™ Growth Modulation System (Braive™ GMS) (DEVICE).
Who is sponsoring clinical trial NCT04929678?
This trial is sponsored by Medtronic Spinal and Biologics, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04929678's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI